2FIRSTS US FDA Rejects Imperial Tobacco's blu 2.4% E Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks Research shows blu vapour significantly reduces in vitro toxicity up to 99% fewer harmful chemicals Imperial Brands Science 2FIRSTS FDA Issues MDO for 4 blu and 1 myblu E cigarette Products FDA denies premarket tobacco product application for blu disposable e cigarette US FDA marketing denial of menthol vapes hailed